Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double blind trial of LdT (telbivudine) versus lamivudine in adults with compensated chronic hepatitis B

Trial Profile

A randomized, double blind trial of LdT (telbivudine) versus lamivudine in adults with compensated chronic hepatitis B

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Telbivudine (Primary) ; Lamivudine
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Acronyms GLOBE
  • Sponsors Idenix Pharmaceuticals; Merck Sharp & Dohme
  • Most Recent Events

    • 01 Feb 2018 Results of retrospective analysis assessing effect of HBV subgenotype on treatment response using patient data from NCT00962533, NCT00057265 and NCT00131742 trials published in the Hepatology Research
    • 01 Feb 2009 2-year results published in Gastroenterology.
    • 20 Dec 2007 Week 52 results published in full in New England Journal of Medicine (NEJM) 357: 2576-2588, No. 25, 20 Dec 2007.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top